![Haeok Lee headshot](/sites/default/files/styles/full_width_fallback_refreshed/public/2023-11/Nov3%20Haeok%20Lee_Profile2_final2.jpg?itok=5BJYxgEv)
Haeok Lee
FAAN PhD RN
Professor
hl5209@nyu.edu
1 212 998 5714
433 FIRST AVENUE
NEW YORK, NY 10010
United States
Haeok Lee's additional information
-
-
Haeok Lee, FAAN, PhD, RN, is a professor at the NYU Rory Meyers College of Nursing. She is an experienced nurse behavioral scientist with extensive clinical and research experience focusing on populations affected by health disparities. Her primary research addresses health inequity issues among immigrant populations through theory and community-based participatory research. Prof. Lee is a pioneer in developing cultural and social context specific storytelling videos for encouraging health behavior changes, specifically in immigrant and African populations.
Prof. Lee initiated cancer research and research capacity building based on her Fulbright Scholarship for Africa from 2017-2000 and recently completed an R21 (1R21NR018734) grant, a pilot RCT, and an mHealth delivered storytelling intervention to promote cervical cancer screening among Malawian women living with HIV. Currently, she serves as a site PI of the Asian Cohort Alzheimer’s disease project (ACAD: U19-AG079774) to recruit 5,081 older Asian adults across the U.S. and Canada. The NYU site focuses on working with the Korean American subpopulation. The study collects DNA, plasma biomarkers, and genotypes, as well as social factors and clinical diagnostic information. For more information read the article NYU Meyers joins NIH-funded multisite study of Alzheimer’s disease in Asian Americans.
Prof. Lee mentors faculty, postdoctoral scholars, PhD students, and undergraduate students from diverse racial/ethnic backgrounds and from various disciplines. She has sponsored overseas visiting scholars.
-
-
Post Doctoral fellowship, University of California San FranciscoPhD, University of California San FranciscoMA, Yonsei University School of EducationBSN, Chosun University
-
-
American Academy of NursingAmerican Association of Public HealthAmerican Alzheimer’s AssociationThe Greater New York Korean Nurses Association
-
-
Faculty Honors Awards
Distinguished Editorial Board Award, Asian Pacific Journal of Oncology (2024)American Nurses Association, Massachusetts Excellence in Nursing Research Awards (2022)The 27th Annual Scientific Conference of Eastern Nursing Research Society (2015)Fellow of American Academy of Nursing (2013)The 24th Annual Scientific Conference of Eastern Nursing Research Society (2012)Excellent Chosun Alumni for Contribution in Education and Social Justice (2012) -
-
Publications
Serial assessment of left ventricular function after myocardial infarction
AbstractLee, H. O., Eisenberg, M. J., & Schiller, N. B. (1995). American Heart Journal, 130(5), 999-1002. 10.1016/0002-8703(95)90200-7AbstractLeft ventricular (LV) function is an important predictor of morbidity and mortality after myocardial infarction (MI). Changes in LV function have been examined during the early and late phases after MI, but serial measurements of LV function during the subacute period have not been performed. To assess sequential changes in LV function during the subacute period after MI, we used quantitative two-dimensional echocardiography to examine 22 patients over a 1-year period. Twenty-one of the 22 patients had a Q-wave MI. Eleven had an anterior MI and 10 had an inferior MI; their peak creatine phosphokinase (CPK) was 1213 mlU/ml ± 14. Three weeks after acute MI, LV ejection fraction (LVEF) had increased from 45% to 52%. Seven of 19 patients showed an LVEF <43% at baseline. In five of these patients, LVEF improved, but in two patients, LVEF was still <43% in week 3. There was a significant enlargement of LV end-diastolic volume (LVEDV) (94 ml to 112 ml, p < 0.05) across the four observations but no change in LV end-systolic volume (LVESV; 54 ml to 56 ml, p = n.s.). When two groups (G1 [depressed], LVEF ≤43%; G2 [preserved], LVEF >43%) were compared, the group with depressed LVEF demonstrated a higher probability of improvement in LVEF (34% to 47%, p < 0.001) and stroke volume (38 ml to 65 ml, p < 0.01).